Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK

Authors:

Emery P, Van Keep M, Beard S, Graham C, Miles L, Jugl SM, Gunda P, Halliday A, Marzo-Ortega H

Publication type:

Journal article

Publication name:

Pharmacoeconomics

Citation:

Emery P, Van Keep M, Beard S, Graham C, Miles L, Jugl SM, Gunda P, Halliday A and Marzo-Ortega H. Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK. Pharmacoeconomics. 2018; 36(8):1015-27.

 

Link to publication ⟶

⟵ Back to Search Results